Pharmaceutical - Blogging About What's Possible

Recent posts

Modern Perspectives on Method Development

By October 21, 2021

Hear from Dr. Fadi Alkhateeb, a Waters Senior Separations Scientist on the approach and tools used to design and develop fit-for-purpose methods.

Categories: Enhanced Method Development
Tags:

BioAccord System with ACQUITY Premier: Some Things Work Better Together

By September 13, 2021

Combining BioAccord, our most capable MS detection platform, with ACQUITY Premier UPLC, our highest performance LC system, to demonstrate superior performance.

Categories: Pharmaceutical
Tags: , , , , , , , , ,

Reliable, Reportable Data with Analytical Quality by Design Approaches

By September 10, 2021

The ways pharmaceutical organizations achieve reliable, reportable data is shifting. We discuss how leveraging modern analytical tools and applying an Analytical Quality by Design approach in your lab can increase the robustness of analytical methods.

Categories: Pharmaceutical
Tags: , , ,

Biopharma’s Future: Next-Generation LC-MS Workflows for Peptide MAM

By March 18, 2021
LC-MS workflows for peptide MAM

The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , , , , ,

Embracing Analytical Techniques Into Regulated Laboratories

By March 2, 2021
biopharma compliance

To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt. Learn how the compliant-ready Waters BioAccord LC-MS platform helps biopharma address the additional compliance challenges posed by the field’s complex analytical instruments.

Categories: Pharmaceutical, Technologies
Tags: , , , ,

Answering the Call with Compliance-Ready LC-MS Solutions for Oligonucleotide Analysis

By December 11, 2020

Oligonucleotides, or short strands of DNA or RNA, continue to increase in popularity. In addition to their essential role as primers and probes in the expanding clinical DNA testing and diagnostics market, they’re also seeing… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , ,

Boosting Biopharma Productivity with Routine LC-MS

By December 1, 2020

As scientific advances continue to carry researchers into new arenas, it is vital that technology evolves in tandem. At Waters, we understand that it is only by leveraging fit-for-purpose technologies that researchers are able to… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , ,

The Evolving Regulations Guiding Nitrosamines

By October 19, 2020

In July 2018, the European Medicines Agency (EMA) reported the recall of a number of products containing the active pharmaceutical ingredient (API) valsartan due to contamination with a known carcinogen, dimethyl nitrosamine, also referred to… Read more >

Categories: Pharmaceutical
Tags:

Mutagenic Impurity Risk Assessment Throughout the Development and Manufacturing Process

By September 15, 2020

Since the early 2000s and the advent of the first guidance relating to mutagenic impurities developed by the European Medicines Agency (EMA), it has been necessary to assess the risk posed by mutagenic impurities.  Although… Read more >

Categories: Pharmaceutical
Tags: , , ,

Bringing the Future Into Focus with Waters’ Virtual Events

By August 25, 2020

In the midst of the COVID-19 pandemic the power of technology has emerged center stage, keeping the industry connected at a time when many ordinary avenues of communication have been cut off over safety concerns.… Read more >

Categories: Automation, Chemical, Columns, COVID-19, Food & Environmental, Leadership, Pharmaceutical, Technologies